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Introduction {#sec1}
============

Excitatory and inhibitory projections onto the lateral habenula (LHb) control the direction of neuronal output, contributing to the encoding of rewarding and aversive stimuli ([@bib32], [@bib33], [@bib34]). Moreover, in rodent models of addiction and depression, glutamatergic and GABAergic synaptic plasticity modulates LHb neuronal firing, which is in turn instrumental for depression-like phenotypes ([@bib20], [@bib24], [@bib27], [@bib33]). This highlights the behavioral relevance of synaptic adaptations in the LHb, heightening the need of understanding its underlying cellular processes.

Group I metabotropic glutamate receptor (mGluR) signaling and expression undergo modifications in disorders such as addiction and depression, disease states also characterized by aberrant LHb neuronal firing ([@bib3], [@bib15], [@bib19]). Group 1 mGluRs consist of mGluR1 and mGluR5 subtypes ([@bib22]). Their activation modulates the strength of excitatory and inhibitory synapses through G~q~/G~11~-mediated calcium mobilization and activation of downstream effectors, including protein kinase C (PKC) ([@bib22], [@bib31]). Pre- and postsynaptic mechanisms underlie mGluR-dependent long-term plasticity, but its relevance for controlling neuronal activity remains poorly understood ([@bib10], [@bib16], [@bib23]).

We combine electrophysiology in LHb-containing acute slices with pharmacology and find that activation of mGluR1 receptors, but not of mGluR5, triggers long-term depression of excitatory and inhibitory synaptic transmission (mGluR-eLTD and mGluR-iLTD, respectively). mGluR-eLTD and -iLTD induction requires postsynaptic PKC signaling, but their maintenance relies on divergent expression mechanisms. mGluR-eLTD occurs via a presynaptic cannabinoid 1 receptor (CB1-R)-dependent decrease in glutamate release. In contrast, mGluR-iLTD is independent of presynaptic changes. Instead, mGluR-iLTD is postsynaptically expressed and requires PKC targeting onto GABA~A~-R β2-subunits and a reduction in GABA~A~-R single-channel conductance. The functional relevance of mGluR activation in the LHb is represented by opposing effects on neuronal output. Indeed, in the LHb, the mGluR-driven modulation of synaptic responses and output firing correlate positively. These data unravel the distinct molecular mechanisms underlying mGluR control of synaptic strength and the subsequent regulation of LHb neuronal activity.

Results {#sec2}
=======

mGluRs Drive Long-Term Synaptic Depression in the LHb {#sec2.1}
-----------------------------------------------------

To examine the presence of group I mGluRs, we micro-dissected the LHb of mice and employed RT-PCR, which revealed mGluR1 and mGluR5 expression ([Figure 1](#fig1){ref-type="fig"}A). Accordingly, bath application (3--5 min) of the mGluR1/5 agonist 3,5-dihydroxyphenylglycine (DHPG, 50 μM) led to a transient inward current ([Figure 1](#fig1){ref-type="fig"}B; [@bib11]). These data indicate the presence of functional postsynaptic group I mGluRs in LHb neurons.

To investigate whether mGluR activation modulates neurotransmission in the LHb, we tested the effect of DHPG application (5 min) on pharmacologically isolated AMPA receptor (AMPA-R)-mediated excitatory and GABA~A~-R-mediated inhibitory postsynaptic currents (excitatory postsynaptic currents \[EPSCs\] and inhibitory postsynaptic currents \[IPSCs\], respectively). DHPG produced long-term depression of EPSCs and IPSCs ([Figures 1](#fig1){ref-type="fig"}C and 1D), termed eLTD and iLTD, respectively. mGluRs are activated by wide ranges of presynaptic activity ([@bib22], [@bib8]). Accordingly, we found that low-frequency stimulation (LFS) of presynaptic fibers (1 Hz) led to eLTD ([Figure 1](#fig1){ref-type="fig"}E). Instead, at inhibitory synapses, high-frequency stimulation (HFS) of presynaptic afferents (100 Hz at 0 mV) triggered iLTD ([Figure 1](#fig1){ref-type="fig"}F). Thus, mGluR activation and a distinct pattern of presynaptic activity in the LHb efficiently reduce excitatory and inhibitory synaptic transmission.

mGluR-eLTD and -iLTD Require mGluR1 and PKC Signaling {#sec2.2}
-----------------------------------------------------

Group I mGluRs comprise mGluR1 and mGluR5 subtypes. To assess the induction requirement for mGluR- eLTD and -iLTD, we first exposed slices to either mGluR1 or mGluR5 antagonists (LY367385 or 3-2-methyl-4-thiazolyl-ethynyl-pyridine \[MTEP\], respectively). The mGluR1 antagonist LY367385 prevented DHPG eLTD/iLTD as well as LFS eLTD and HFS iLTD ([Figures 2](#fig2){ref-type="fig"}A and 2B; [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Although the LFS protocol also reduced IPSCs, LY367385 failed to block this form of plasticity, indicating a different mechanism of induction ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Importantly, DHPG eLTD and iLTD remained intact in presence of the mGluR5 antagonist MTEP ([Figures 2](#fig2){ref-type="fig"}C and 2D).

Downstream of mGluRs, the G~q~-coupled cascade leads to PKC activation, which targets a wide spectrum of synaptic proteins crucial for synaptic adaptations ([@bib22]). To test PKC implication for mGluR-eLTD and -iLTD, we dialyzed neurons through a patch pipette with a pseudosubstrate peptide inhibitor of PKC, PKC\[19-36\] ([@bib30]). mGluR-eLTD and -iLTD were abolished in the presence of PKC\[19-36\] ([Figures 2](#fig2){ref-type="fig"}E and 2F). If PKC underlies mGluR-eLTD and -iLTD, we reasoned that its activation would occlude mGluR-driven synaptic plasticity. To test this, we bath-applied the PKC activator phorbol-12-myristate-13-acetate (PMA). When PMA successfully decreased EPSCs and IPSCs (seven of ten and five of six cells, respectively; [Figures 2](#fig2){ref-type="fig"}G and 2H), subsequent DHPG application failed to further reduce excitatory and inhibitory synaptic responses ([Figures 2](#fig2){ref-type="fig"}G and 2H). These data indicate that mGluR activation decreases excitatory and inhibitory synaptic transmission via a common mechanism requiring mGluR1-driven PKC signaling.

Presynaptic Expression Mechanism of eLTD in the LHb {#sec2.3}
---------------------------------------------------

Excitatory synapses in the LHb contain GluA2-lacking AMPA-Rs, as indicated by inwardly rectifying EPSCs ([@bib24]). In brain structures such as the ventral tegmental area, nucleus accumbens, and cerebellum, the presence of GluA2-lacking AMPA-Rs is a requirement for mGluRs to trigger postsynaptic LTD. This form of plasticity occurs via a switch from GluA2-lacking high-conductive to GluA2-containing low-conductive AMPA-Rs ([@bib2], [@bib17], [@bib25]). To test whether this scenario also applies to the LHb, we evoked EPSCs at different holding potentials (--60, 0, and +40 mV) before and after mGluR-eLTD ([Figure 3](#fig3){ref-type="fig"}A). EPSCs at baseline were inwardly rectifying, yielding a rectification index of \>1, indicative of GluA2-lacking AMPA-R expression. DHPG reduced EPSC amplitude at negative and positive potentials, leaving the rectification index unaltered ([Figure 3](#fig3){ref-type="fig"}A). Thus, mGluR-eLTD in the LHb does not require postsynaptic modifications of AMPA-R subunit composition.

Aside from postsynaptic modifications, mGluRs can also trigger presynaptic long-term adaptations. To examine whether a decrease in presynaptic glutamate release underlies mGluR-eLTD, we monitored the paired-pulse ratio (PPR) of EPSCs before and after DHPG and LFS. Along with the reduced EPSC amplitude, DHPG application as well as the LFS produced a long-lasting increase in the PPR, indicating reduced glutamate release ([Figure 3](#fig3){ref-type="fig"}B; [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). In line with the mGluR1 and PKC requirements for mGluR-eLTD, the PPR remained unaltered after DHPG in the presence of the mGluR1 antagonist and PKC inhibitor but not in the presence of the mGluR5 blocker ([Figure 3](#fig3){ref-type="fig"}B). Interestingly, PMA-driven reduction in EPSCs occurred along with an increased PPR, which remained unaffected after subsequent DHPG application ([Figure 3](#fig3){ref-type="fig"}B). The different pharmacological agents did not alter the baseline PPR, suggesting the absence of drug-induced modifications in the probability of glutamate release ([Figure 3](#fig3){ref-type="fig"}B; black columns for all conditions). To corroborate our findings on the presynaptic mechanism underlying mGluR-eLTD, we examined quantal release by recording miniature EPSCs (mEPSCs). In the presence of tetrodotoxin, DHPG application led to a decrease in mEPSC frequency without significant changes in mEPSC amplitude ([Figure 3](#fig3){ref-type="fig"}C). This supports a scenario for a presynaptic expression of mGluR-eLTD. mGluR activation can trigger the release of endocannabinoids from postsynaptic neurons in several brain structures, including the striatum, hippocampus, and ventral tegmental area. mGluR-driven endocannabinoid mobilization acts retrogradely on presynaptic CB1-Rs, negatively modulating neurotransmitter release ([@bib12]). However, whether mGluRs trigger endocannabinoid signaling within the LHb is unknown. We first tested whether CB1-Rs are functionally expressed in the LHb. The CB1-R agonist WIN-55,212-2 reduced EPSC amplitude and increased the PPR ([Figures 3](#fig3){ref-type="fig"}D and 3E). This intervention occluded DHPG eLTD, suggesting that mGluR-eLTD expresses through CB1-R activation ([Figures 3](#fig3){ref-type="fig"}D and 3E). We pharmacologically confirmed that CB1-Rs are required for WIN-55,212-2-driven EPSC reduction because this was prevented by bath application of the CB1-R neutral antagonist NESS-0327 ([@bib26]; [Figures 3](#fig3){ref-type="fig"}F and 3G). Consistent with the idea that CB1-Rs underlie the presynaptic expression of mGluR-eLTD, NESS-0327 also prevented mGluR-dependent plasticity and the concomitant increase in PPR ([Figures 3](#fig3){ref-type="fig"}H and 3I). This suggests that mGluR-eLTD requires a PKC-dependent and CB1-Rs-mediated reduction in presynaptic glutamate release.

Postsynaptic Mechanisms for mGluR-iLTD in the LHb {#sec2.4}
-------------------------------------------------

Because mGluR-driven endocannabinoid mobilization can also modulate GABA transmission ([@bib8]), we questioned whether mGluR-iLTD requires a reduction in GABA release. We first examined the PPR of IPSCs before and after DHPG or HFS. mGluR-iLTD and HFS-iLTD occurred without PPR modifications, independent of the pharmacological intervention, suggesting the absence of presynaptic adaptations at inhibitory synapses ([Figure 4](#fig4){ref-type="fig"}A; [Figures S2](#mmc1){ref-type="supplementary-material"}B and S2D). In line with this finding, mIPSC frequency remained unchanged, whereas mIPSCs amplitude decreased after DHPG application ([Figure 4](#fig4){ref-type="fig"}B). Moreover, NESS-0327 did not prevent the mGluR-dependent reduction in GABAergic transmission ([Figure 4](#fig4){ref-type="fig"}C). Together, these findings support that mGluR-iLTD is independent of endocannabinoid-driven presynaptic modifications. These data suggest instead a postsynaptic expression mechanism for mGluR-iLTD in contrast to the presynaptically expressed mGluR-eLTD.

Whether and how mGluR-PKC signaling modulates postsynaptic GABA~A~-R function remains unknown. PKC can directly target GABA~A~-Rs as well as auxiliary proteins modifying receptors' membrane expression and function ([@bib18]). For instance, PKC activation can increase GABA~A~-R internalization via a dynamin-dependent mechanism ([@bib13]). To examine whether mGluR-iLTD in the LHb requires GABA~A~-R internalization, we dialyzed neurons with a membrane-impermeable dynamin inhibitor to prevent endocytosis. This intervention left mGluR-iLTD intact ([Figure 4](#fig4){ref-type="fig"}D), suggesting that GABA~A~-R internalization is not required. To corroborate the absence of changes in the number of postsynaptic GABA~A~-Rs during mGluR-iLTD, we employed peak-scaled non-stationary fluctuation analysis (NSFA) of mIPSCs ([@bib24], [@bib29]). Based on the stochastic closing of ion channels, this statistical method allows us to estimate the number of receptors opened (N) by neurotransmitter release as well as their single-channel conductance (γ). Plotting the decay variance as a function of the mean current amplitude for all recorded neurons yielded γ~GABA-A-R~ values comparable to previous studies (31.4 ± 1 pS; [Figures 4](#fig4){ref-type="fig"}E and 4F; [@bib29]). DHPG decreased estimated γ~GABA-A-Rs~ without altering estimated N~GABA-A-Rs~ ([Figures 4](#fig4){ref-type="fig"}E and 4F). Together, this supports the absence of mGluR-driven GABA~A~-R internalization. Conversely, a reduction in γ~GABA-A-R~ suggests a decrease in GABA~A~-R function, a modulation that may result from subunit-specific PKC-mediated phosphorylation ([@bib18]). Consistently, PKC-driven phosphorylation of specific serine residues on the GABA~A~-R β1-3 and γ2 subunits reduces receptor function without altering the total receptor pool ([@bib5], [@bib9], [@bib18]). Given the reported expression of GABA~A~-R β2 and γ2 subunits within the LHb ([@bib14]), we predicted that the described mGluR-iLTD results from the direct PKC modulation of specific GABA~A~-R subunits. To test this, we dialyzed dominant-negative peptides corresponding to the PKC-targeted sequences of GABA~A~-R β2 or γ2 subunits ([@bib4], [@bib9]). The presence of the β2 peptide (GABA~A~-β2) prevented mGluR-iLTD. In contrast, mGluR-eLTD and the concomitant PPR increase remained intact, ruling out non-specific actions of GABA~A~-β2 dialysis ([Figures 4](#fig4){ref-type="fig"}G and 4H; [Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Intracellular infusion of the γ2 peptide (GABA~A~-γ2) did not affect the expression of mGluR-iLTD or mGluR-eLTD ([Figures 4](#fig4){ref-type="fig"}I and 4J; [Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). These data suggest that mGluRs trigger a PKC-dependent reduction in GABA~A~-R conductance, likely occurring via phosphorylation of the β2 but not γ2 receptor subunits.

mGluRs Decide the Direction of LHb Neuronal Output {#sec2.5}
--------------------------------------------------

Opposed motivational states (i.e., reward and aversion) require bidirectional modification of LHb neuronal output, which can result in part from glutamatergic and GABAergic synaptic adaptations ([@bib32], [@bib34], [@bib27]). What would be the functional repercussions of mGluR-eLTD and iLTD for LHb activity? To test the consequences of mGluR-LTD on LHb neuronal output, we recorded synaptically evoked postsynaptic potentials (PSPs) in current clamp mode. In the absence of synaptic blockers, PSPs result from a mixture of glutamatergic and GABAergic components and are therefore susceptible to mGluR-eLTD and -iLTD. We delivered trains of ten stimuli (20 Hz) and set the stimulation intensity so that ∼50% of evoked PSPs would produce action potentials (APs) ([Figure 5](#fig5){ref-type="fig"}A). Ten minutes after DHPG washout, a time point where mGluR-eLTD and -iLTD are fully expressed, AP numbers either increased or decreased (\>20% change in APs) in ∼64% of neurons. Because of this dual modulation, DHPG did not, on average, modify the extent of evoked APs ([Figure 5](#fig5){ref-type="fig"}A). However, the bidirectional mGluR-driven change in neuronal activity may result from the expression of either mGluR-eLTD or -iLTD. Therefore, we examined whether the direction of LHb neuronal output after DHPG application correlates with mGluR-mediated modulation of PSPs. The area under individual PSPs (not including APs) was computed and averaged before and after DHPG to assess the PSPs potentiation or inhibition after mGluR activation. We predicted that the mGluR-mediated increase in PSPs would facilitate firing as a consequence of mGluR-iLTD. Conversely, predominant mGluReLTD would reduce the PSP area, decreasing neuronal output. In line with this scenario, the mGluR-driven change in PSP area positively correlated with the DHPG-driven modulation of AP number ([Figures 5](#fig5){ref-type="fig"}A and 5B). To determine the causality between mGluR-eLTD/iLTD and the firing adaptations, we prevented the expression mechanisms underlying mGluR-LTD at excitatory and inhibitory synapses. Concomitantly blocking CB1-R and PKC action on GABA~A~-β2 receptors led to DHPG-driven modulation of LHb neuronal firing (\>20% change in APs) in only 12.5% of recorded neurons. Under this condition, no correlation occurred between PSP area and firing after mGluR activation ([Figures 5](#fig5){ref-type="fig"}C and 5D). In contrast, independently preventing either mGluR-eLTD or -iLTD expression mechanisms revealed a marked bidirectional DHPG-induced modulation of evoked firing ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Furthermore, input resistance and AP properties did not change or correlate with DHPG-mediated firing changes ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3H).

If the occurrence of mGluR-dependent plasticity differs at excitatory or inhibitory synapses from specific inputs, this would partly explain the predominant influence of either mGluR-eLTD or -iLTD on neuronal output. LHb neurons receive axons from the entopeduncular nucleus (EPN, EPN^LHb^) that co-release glutamate and GABA ([@bib32]). This allows us to examine whether mGluR-LTD occurs in a neurotransmission-specific fashion at a precise synaptic input. As a proof of concept, we virally expressed channelrhodopsin-2 (ChR2) in the EPN. This led to ChR2^+^ terminals within the lateral aspect of the LHb ([@bib32], [@bib28]; [Figure S4](#mmc1){ref-type="supplementary-material"}A). DHPG bath application triggered a LTD of light-evoked EPN^LHb^ IPSCs, whereas light-evoked EPN^LHb^ EPSCs remained unaffected ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). Together, these findings suggest that mGluRs in the LHb can control the direction of neuronal activity, likely via input-specific eLTD or iLTD.

Discussion {#sec3}
==========

Here we demonstrate that group I mGluRs decrease excitatory and inhibitory synaptic transmission in the LHb in a PKC-dependent manner. On one hand, mGluR1-driven PKC activation in LHb represents a common process at excitatory and inhibitory synapses. On the other hand, mGluR1 signaling diverges at the level of PKC, targeting distinct substrates but leading to decreased glutamatergic and GABAergic neurotransmission. mGluR-eLTD and -iLTD modulate PSPs to decide the direction of LHb neuronal output. Our data support a scenario in which mGluRs modulate glutamatergic and GABAergic synapses in the LHb, contributing to adaptations in their computational properties potentially relevant for motivational states.

Notably, excitatory synapses in the LHb contain rectifying GluA2-lacking AMPA-Rs ([@bib24]). A recent hypothesis posits that GluA2-lacking AMPA-R expression represents a predictive factor for a postsynaptic mGluR1-LTD requiring a subunit composition switch ([@bib21]). However, mGluR1 activation in the LHb reduces excitatory synaptic transmission while leaving the GluA2-lacking AMPA-R current-voltage relationship unchanged. This unaffected AMPA-Rs rectification may result from LHb-specific interactions between receptors and scaffolding proteins or, alternatively, from unidentified AMPA-Rs subtypes that would need to be further investigated.

In contrast, mGluR1s in the LHb act through postsynaptic PKC signaling to reduce glutamate release via CB1-R activation. Together with evidence indicating that LHb contains the endocannabinoid-synthesizing enzyme diacylglicerol lipase ([@bib35]), our data support functional endocannabinoid signaling within the LHb. mGluR-driven endocannabinoid LTD is also observed at inhibitory synapses ([@bib8]); however, this does not hold true in the LHb. Indeed, mGluR-iLTD is independent of presynaptic modifications and remains intact in the presence of CB1-R blockers. Although mGluR-iLTD does not require CB1-Rs, other G~q~ protein-coupled receptors (GPCRs) may mobilize endocannabinoids to drive iLTD. Future studies need to address whether CB1-R activation modifies GABA transmission or whether other GPCRs mediate endocannabinoid-dependent iLTD in the LHb.

Although PKC mediates the presynaptic expression of mGluR-eLTD, it reduces GABA transmission through a postsynaptic mechanism. Importantly, postsynaptic PKC signaling controls the strength of inhibitory neurotransmission ([@bib18]). For instance, PKC can induce rapid internalization of GABA~A~-Rs through its actions on specific serine residues ([@bib7], [@bib13]). However, mGluR-iLTD in the LHb is independent of dynamin-mediated endocytosis and does not involve a reduction in the number of activated receptors. Instead, mGluRs promote a reduction in GABA~A~-R single-channel conductance. This modification in GABA~A~-R function may result from alterations in subunit composition, scaffolding proteins, and phosphorylation events ([@bib18]). Indeed, PKC reduces GABA~A~-R function, but not receptor expression, via phosphorylation of key residues on the GABA~A~-R β and γ subunits ([@bib4], [@bib6], [@bib9]). We report that PKC action on GABA~A~-R β2-subunits, but not on γ2 subunits, is crucial for mGluR-iLTD in the LHb. Interestingly, different subtypes of G~q~-PCRs other than group I mGluRs (i.e., muscarinic acetylcholine and serotonin receptors) also reduce GABA~A~-R function by PKC targeting of GABA~A~-R β1 and γ2 subunits ([@bib9], [@bib5]). This evidence therefore raises the possibility that different classes of G~q~-PCRs across the CNS may reduce synaptic inhibition via PKC phosphorylation of specific GABA~A~-R subunits (i.e., β2, γ2, β1) ([@bib6], [@bib9], [@bib18]).

mGluR-eLTD and -iLTD are widespread across many synapses ([@bib8]), but their functional repercussions on neuronal output remain elusive. mGluR1 can affect potassium and calcium conductances, crucial for neuronal activity ([@bib1]). However, the reported absence of changes in input resistance and AP properties suggests that mGluR-driven modulation of neuronal activity likely arises from synaptic adaptations. The mGluR-dependent potentiation and inhibition of PSPs indeed predicts the direction of neuronal output after mGluR activation. Moreover, precluding mGluR-eLTD and -iLTD concomitantly or independently unravels the causality between synaptic plasticity and mGluR-dependent control of LHb neuronal firing. This result also suggests that mGluR-eLTD and -iLTD likely do not occur simultaneously at the same locus and with the same extent. Instead, one predominates over the other, to drive, in different neurons, opposite neuronal output changes. mGluR-eLTD and -iLTD may occur together with similar magnitude but on distinct postsynaptic sites or even distinct LHb neuronal populations. In both cases, mGluR plasticity would ultimately lead to a bidirectional modulation of LHb global activity. These scenarios may rely, to some degree, on circuit specificity. The observation that the EPN^LHb^ GABAergic but not glutamatergic component is affected by mGluRs strongly suggests that, in the LHb, mGluR1 modulation may occur in a neurotransmission- and input-specific fashion. This is in in line with our data indicating that different patterns of activity trigger either mGluR-eLTD or -iLTD, and it is further supported by findings describing that input/output-specific plasticity controls LHb output firing ([@bib33], [@bib28]). In conclusion, these findings identify how mGluR1 signaling in the LHb diverges at the level of PKC, leading to reduced presynaptic glutamate release and postsynaptic GABA~A~-R function. Based on our results, we speculate that mGluR-LTD in the LHb can decide the direction of neuronal activity, potentially influencing opposing motivational states.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

C57Bl/6J male mice (∼30 days old) were used in accordance with the guidelines of the French Agriculture and Forestry Ministry for handling animals, and protocols were validated by the Darwin\#5 ethical committee of the University Pierre et Marie Curie. Mice were anesthetized (i.p.) with ketamine (150 mg/kg)/xylazine (100 mg/kg) (Sigma-Aldrich) prior to brain slice preparation or viral injections ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

In Vitro Electrophysiology {#sec4.2}
--------------------------

Sagittal slices (250 μm) containing the LHb were prepared, and recordings were performed as described previously ([@bib24]). For voltage clamp experiments, the internal solution contained 130 mM CsCl, 4 mM NaCl, 2 mM MgCl~2~, 1.1 mM EGTA, 5 mM HEPES, 2 mM Na~2~ATP, 0.6 mM Na~3~GTP, 5 mM Na^+^ creatine phosphate, 2 mM QX-314, and 0.1 mM spermine; (pH 7.3), osmolarity ∼300 mOsm. The holding potential was --50 mV. Synaptic currents were evoked through a glass pipette placed in the stria medullaris (60 μs at 0.1 Hz). The PPR was monitored (2 pulses, 20 Hz) and calculated as follows: EPSC~2~/EPSC~1~. mGluRs were activated by DHPG (50 μM) in the presence of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo\[f\]quinoxaline-2,3-dione (NBQX; 10 μM) and D-(2*R*)-amino-5-phosphonovaleric acid; (2*R*)-amino-5-phosphonopentanoate (D-APV; 50--100 μM) or picrotoxin (100 μM). An LFS protocol (1 Hz, 15 min) or an HFS protocol (100 Hz at 0 mV for 1 s, 5 times every 10 s) was used for synaptic activation of mGluRs. The rectification index of AMPA-EPSCs was calculated as follows: ((*I*~EPSC(--60)~/*I*~EPSC(+40)~)/1.5). Experiments assessing the postsynaptic effects of DHPG (voltage clamp) and output firing (current clamp) were performed with internal solution containing 140 mM KGluconate, 5 mM KCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM MgCl~2~, 4 mM Na~2~ATP, 0.3 mM Na~3~GTP, and 10 mM creatine phosphate; (pH 7.3), osmolarity ∼300 mOsm. The input resistance was calculated via a 50-ms hyperpolarizing current (I = 20 pA) step (Ri = resting membrane potential \[RMP\]/I).

Non-stationary Fluctuation Analysis {#sec4.3}
-----------------------------------

A peak-scaled non-stationary fluctuation analysis was made from mIPSCs (Synaptosoft; [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Drugs and Peptides {#sec4.4}
------------------

Drugs were obtained from Abcam, Tocris, Hello Bio, or Latoxan and dissolved in water. Tetrodotoxin (TTX) was dissolved in citric acid (1%); picrotoxin, NESS-0327, WIN-55,212-2, and PMA in DMSO; and LY367385 in NaOH 10%. For PMA experiments, only cells responding to drug application were included in the analysis. Peptides used in the study were custom-made (GeneScript) or obtained from Tocris ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) and, when indicated, included in the internal solution.

Analysis {#sec4.5}
--------

Analysis was performed using IGOR-6 (Wavemetrics) and MiniAnalysis (Synaptosoft). Kolmogorov-Smirnov (KS) test, Student's t test, or ANOVA were used throughout the study. n in the figures indicates number of recorded neurons. All data are expressed as mean ± SEM. Significance was set at alpha = 0.05 using paired t test.
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![mGluR-eLTD and -iLTD in the LHb\
(A) Schematic depicting the LHb microdissection (hipp, hippocampus; thal, thalamus) and mGluR1 and mGluR5 expression in the LHb. MW, molecular weight; bp: base pairs.\
(B) Sample trace, bar graph, and scatterplot representing DHPG-evoked current (−28.5 ± 4.6 pA, 12 of 22 responding neurons).\
(C) Sample traces representing EPSCs at baseline (a) and 20 min following DHPG (b). The timeline represents the DHPG effect (50 μM) on EPSCs. The bar graph and scatterplot show normalized averaged EPSCs ∼40 min after DHPG (66.3 ± 5%, t~19~ = 6.306, ^∗∗∗^p \< 0.0001).\
(D) The same as (C) but for IPSCs (69.9 ± 7.3%, t~17~ = 4.235, ^∗∗∗^p \< 0.0001).\
(E) LFS-driven (1 Hz, 15 min) eLTD. The bar graph and scatterplot show normalized averaged EPSCs ∼40 min after the protocol (65.8 ± 6.4%, t~9~ = 5.3, ^∗∗∗^p \< 0.0001).\
(F) HFS-driven (100 Hz, 1 s, at 0 mV) iLTD (top). The bar graph and scatterplot show normalized averaged IPSCs ∼40 min after the protocol (74.2 ± 3.9%, t~6~ = 7.086, ^∗∗∗^p \< 0.0001).\
When not indicated, the timescale represents 5 ms. Error bars represent SEM. n indicates number of recorded neurons.](gr1){#fig1}

![mGluR1 and PKC-Dependent Induction for eLTD and iLTD\
(A) DHPG effect on EPSCs in the presence of the mGluR1 antagonist LY367385 (91.1 ± 5.6%, t~9~ = 2.063, p \> 0.05).\
(B) The same as (A) but for IPSCs (88.7 ± 6.7%, t~8~ = 1.680, p \> 0.05).\
(C) DHPG effect on EPSCs in the presence of the mGluR5 antagonist MTEP (74.5 ± 10.8%, t~8~ = 2.377, ^∗^p \< 0.05).\
(D) The same as (C) but for IPSCs (71 ± 8.7%, t~6~ = 3.425, ^∗^p \< 0.05).\
(E) DHPG effect on EPSCs during intracellular dialysis of PKC\[19-36\] (99.2 ± 14.8%, t~9~ = 0.066, p \> 0.5).\
(F) The same as (E) but for IPSCs (98.1 ± 9.1%, t~6~ = 0.088, p \> 0.05).\
(G) Effect of PMA on EPSCs (b, baseline versus PMA, 68.2 ± 2.4%, t~6~ = 13.39, ^∗∗∗^p \< 0.0001) and subsequent occlusion of DHPG eLTD (c, PMA versus post-DHPG, 64.2 ± 5%, t~6~ = 1.260, p \> 0.05).\
(H) The same as (G) but for IPSCs (b, baseline versus PMA, 62.7 ± 8.7%, t~4~ = 4.285, ^∗^p \< 0.05; c, PMA versus post-DHPG, 61.7 ± 14.4%, t~4~ = 0.155, p \> 0.05).\
Error bars represent SEM. n indicates number of recorded neurons.](gr2){#fig2}

![mGluR-eLTD Expression via CB1-R Activation\
(A) Sample traces of AMPA-EPSCs at --60, 0, and +40 mV at baseline and after DHPG and average rectification index (baseline 3.6 ± 0.7 versus post-DHPG 3.5 ± 0.6, t~8~ = 0.192, p \> 0.05).\
(B) PPR of EPSCs in artificial cerebrospinal fluid (ASCF; baseline 0.62 ± 0.05 versus post-DHPG 0.9 ± 0.05, t~19~ = 4.963, ^∗∗∗^p \< 0.0001); in the presence of LY367385 (baseline 0.53 ± 0.08 versus post-DHPG 0.64 ± 0.11, t~7~ = 1.860, p \> 0.05); of MTEP (baseline 0.59 ± 0.08 versus post-DHPG 0.79 ± 0.08, t~8~ = 3.432, ^∗∗^p \< 0.01); of PKC\[19-36\] in the recording pipette (baseline 0.7 ± 0.1 versus post-DHPG 0.76 ± 0.1, t~9~ = 1.214, p \> 0.05); after PMA and PMA + DHPG (baseline 0.57 ± 0.08 versus PMA 0.74 ± 0.07, t~6~ = 2.799,^∗^p \< 0.05; PMA baseline versus PMA post-DHPG, t~6~ = 0.829, p \> 0.05). Shown are neurons represented in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}. One-way ANOVA among all baseline PPR conditions: F~(9,\ 83)~ = 0.485, p \> 0.05.\
(C) Top: sample traces for mEPSCs. Cumulative probability plots show amplitudes and inter-event intervals for mEPSCs at baseline (black) and after DHPG (red). (mEPSC amplitude: baseline 30 ± 3.8 pA versus post-DHPG 32.1 ± 4.1 pA, KS test, p \> 0.05; mEPSC frequency: baseline 3.8 ± 1.6 Hz versus post-DHPG 2.5 ± 1.1 Hz, KS test, ^∗^p \< 0.05).\
(D) Effect of WIN-55,212-2 on EPSCs (72.7 ± 3.8%, t~5~ = 7.246, ^∗∗∗^p \< 0.001) and subsequent occlusion after DHPG application (68.5 ± 3.9%, t~5~ = 5.559, p \> 0.05).\
(E) PPR of EPSCs after WIN application and subsequent DHPG application (baseline 0.45 ± 0.02, post-WIN 0.67 ± 0.05, post-DHPG 0.71 ± 0.06; baseline versus post-WIN, t~5~ = 3.411, ^∗^p \< 0.05; post-WIN versus post-DHPG, t~5~ = 1.004, p \> 0.05).\
(F) The same as (D) but in the presence of NESS-0327 (90.79 ± 9.02%, t~5~ = 1.001, p \> 0.05).\
(G) The same as (E) but in the presence of NESS-0327 (baseline 0.54 ± 0.09 versus post-WIN 0.57 ± 0.06, t~5~ = 0.672 p \> 0.05).\
(H) Effect of DHPG on EPSCs in the presence of NESS-0327 (95.9 ± 4.3%, t~11~ = 0.766, p \> 0.05).\
(I) PPR after DHPG in the presence of NESS-0327 (baseline 0.58 ± 0.03 versus post-DHPG 0.63 ± 0.06, t~11~ = 1.404, p \> 0.05).\
Error bars represent SEM. n indicates number of recorded neurons.](gr3){#fig3}

![PKC Action on the GABA~A~-Rs-β2 Subunit Underlies mGluR-iLTD\
(A) PPR of IPSCs after DHPG (baseline 0.64 ± 0.07 versus post-DHPG 0.73 ± 0.06, t~17~ = 1.739, p \> 0.05).\
(B) Top: sample traces of mIPSCs. Cumulative probability plots show inter-event intervals and amplitudes for IPSCs at baseline (black) and after DHPG (blue) (mIPSC amplitude: baseline 41.3 ± 5.9 pA versus post-DHPG 39.2 ± 4.83 pA, KS test, ^∗∗^p \< 0.01; mIPSC frequency: baseline 3.6 ± 1.09 Hz versus post-DHPG 3.45 ± 1.13 Hz, KS test, p \> 0.05).\
(C) Effect of DHPG on IPSCs in the presence of NESS-0327 (79.1 ± 7.06%, t~10~ = 2.621, ^∗^p \< 0.05).\
(D) DHPG effect on IPSCs in the presence of intracellular dynamin inhibitor (75.2 ± 10.2%, t~8~ = 2.378, ^∗^p \< 0.05).\
(E) Example of peak-scaled NSFA of mIPSCs at baseline (black) and after DHPG (blue). Insets, overlay and average of analyzed traces.\
(F) Pooled data for N and γ after NSFA (N: baseline 37 ± 6.3 versus post-DHPG 39.3 ± 5.6; t~13~ = 0.8, p \> 0.05; γ: baseline 31.4 ± 1 versus post-DHPG 27.2 ± 1.4; t~13~ = 2.4, ^∗^p \< 0.05).\
(G) The same as (D) but in the presence of intracellular GABA~A~-β2 peptide (97.7 ± 10.4%, t~13~ = 0.225, p \> 0.05).\
(H) The same as (G) but for EPSCs (78.8 ± 6.3%, t~6~ = 3.488, ^∗^p \< 0.05).\
(I) The same as (G) but in the presence of intracellular GABA~A~-γ2 peptide (67.7 ± 5.5%, t~8~ = 6.141, ^∗∗∗^p \< 0.001).\
(J) The same as (I) but for EPSCs (77.7 ± 7.4%, t~7~ = 3.014, ^∗^p \< 0.05).\
Error bars represent SEM. n indicates number of recorded neurons.](gr4){#fig4}

![mGluR-Dependent Bidirectional Control of LHb Neuronal Output\
(A) DHPG effect on synaptically evoked AP numbers in ACSF (97.7 ± 19.6; t~13~ = 0.13, p \> 0.05). 4 of 14 recorded neurons increased in firing (blue), and 5 of 14 decreased in firing (red) following DHPG. Sample traces indicate the bidirectional nature (blue increased firing, red decreased firing) of mGluR activation. Shown are superimposed EPSPs at baseline (black) and after DHPG (blue, increased firing; red, decreased firing).\
(B) Correlation between normalized mGluR-driven firing and normalized PSP area (Pearson correlation, r = 0.75, ^∗∗^p \< 0.01).\
(C) The same as (A) but in the presence of NESS-0327 and GABA~A~-β2 peptide in the internal solution (109.2 ± 8.2, t~7~ = 1.12, p \> 0.05). Black and gray traces represent before and after DHPG.\
(D) The same as (B) but in the presence of NESS-0327 in the ACSF and GABA~A~-β2 peptide in the internal solution (Pearson correlation, r = −0.12, p \> 0.05). Fisher r-to-z transformation for (B) versus (D) correlations yielded a *Z* score of 2.03. ^∗^p \< 0.05.\
(E) Schematic indicating the induction and expression mechanisms for mGluR-eLTD and -iLTD and their relative contribution to LHb neuronal output.\
Error bars represent SEM. n indicates number of recorded neurons.](gr5){#fig5}
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